Assessing Health-Related Quality of Life and Willingness to Pay for Weight Management in Asia-Pacific by Gender
NCT ID: NCT06260696
Last Updated: 2024-02-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
3000 participants
OBSERVATIONAL
2023-08-10
2023-10-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevalence and Economic Burden of Obesity-related Comorbidities in the Gulf Region: A Retrospective, Observational Study
NCT06288399
Impact of Health Lifestyle on Body Weight
NCT05608226
Awareness, Care & Treatment In Obesity Management - An Observation in Asia Pacific
NCT05250427
Physiological Impact of Surgical Mask and N95 Mask on Obese Operating Room
NCT05950256
Impact of Weight Loss Surgery in Adolescents With NAFLD
NCT02952170
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normal weight
Adults with normal weight, recruited to complete self-administered online service
No treatment is given
No treatment is given
Overweight
Adults with overweight, recruited to complete self-administered online service
No treatment is given
No treatment is given
Obesity Class I
Adults with obesity class I, recruited to complete self-administered online service
No treatment is given
No treatment is given
Obesity Class II
Adults with obesity class II, recruited to complete self-administered online service
No treatment is given
No treatment is given
Obesity Class III
Adults with obesity class III, recruited to complete self-administered online service
No treatment is given
No treatment is given
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No treatment is given
No treatment is given
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Male or female, age above or equal to 18 years at the time of signing informed consent.
3. Not currently pregnant
4. Does not participate in intense fitness or body building program
5. Weight loss not through illness or injury
6. Lives in South Korea, Australia, or India
7. BMI above or equal to 18 and associated weight class (Normal Weight or above) will be determined by a programmed calculation based on participant-reported height and weight.
Exclusion Criteria
2. Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Novo Nordisk A/S
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Transparency (dept. 2834)
Role: STUDY_DIRECTOR
Novo Nordisk A/S
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Novo Nordisk Investigational Site
Dubai, , United Arab Emirates
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
U1111-1282-5512
Identifier Type: OTHER
Identifier Source: secondary_id
DAS-7626
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.